This House bill would help sustainable aviation fuel take off

November 19, 2020
Today, we look at a House bill that would boost R&D of sustainable aviation fuel as well as the future of science in America. (876 words, 4 minutes, 22 seconds)
BIO

Today, we look at a House bill that would boost R&D of sustainable aviation fuel as well as the future of science in America. (876 words, 4 minutes, 22 seconds)

 

This House bill would help sustainable aviation fuel take off

 
 

Sustainable aviation fuel is getting attention in Congress with the introduction of a bill that would incentivize R&D. Here’s a look at the legislation and the benefits for people, the planet, and the economy.

Rep. Julia Brownley (D-CA) introduced the Sustainable Aviation Fuel Act, legislation that would provide incentives for the production of sustainable aviation fuel (SAF) and therefore help the aviation industry reduce carbon emissions. 

“Aviation alone contributes 9% to U.S. greenhouse gas emissions from the transportation sector and is therefore a critical target toward achieving our climate goals,” Rep. Brownley said in a statement

Derived from renewable biomass or waste byproducts,SAF has been shown to reduce the carbon footprint of aviation fuel by up to 80% over the full lifecycle. 

Biotech companies have led the way in developing and deploying SAF—like Gevo’s low-carbon fuel made from plant material, LanzaTech's aviation fuel made from carbon emissions, and the World Energy/SkyNRG partnership with Alaska Airlines and Microsoft. But a focused federal response would bolster R&D and investment. 

What it means for health: Tackling climate change is a global priority, and tackling air pollution is critically important, too—especially since study after study shows poor air quality increases the risk of COVID-19 complications and death. 

What it means for the economy: The development and use of SAF can boost the bioeconomy, too. These facilities are often located in rural communities and create job growth and a value-added market for feedstocks as commodity prices plummet. 

Stephanie’s Sage Words: Incentivizing the development of SAF has many environmental and economic benefits. Reducing emissions in aviation is one step forward in the fight against climate change, while also cleaning the air and improving human health. It also provides much-needed assistance to the hard-hit airline industry, and a boost to our bioeconomy. We applaud Rep. Brownley for her leadership in introducing this legislation that will advance innovations in biotechnology and spur the development of sustainable fuels for air travel. – Stephanie Batchelor, VP of BIO’s Industrial and Environment Section

Learn more about sustainable aviation fuels.

Listen: Gevo CEO Pat Gruber joined the I AM BIO Podcast to talk about the company’s jet fuel made with renewable plant material and genetic engineering. Visit www.bio.org/podcast or listen via AppleGoogleSpotify, or wherever you get your podcast fix.

 
 
 
Twitter
 
LinkedIn
 
Facebook
 
 

The future of science in America

 
 

BIO President and CEO Dr. Michelle McMurry-Heath joined the Aspen Institute for The Future of Science in America Summit, where she discussed how far we’ve come in the COVID-19 fight and the high stakes for science ahead.

The good news: The biopharma industry has launched 800+ R&D programs in eight months targeting COVID-19, including 191 vaccines—and we’ve gotten even closer to the finish line with positive results from Moderna’s and Pfizer’s phase 3 trials and emergency use authorization for Eli Lilly’s antibody cocktail

But “uncertainty at the federal level” could lead to challenges,Dr. Michelle told Plus1Vote’s Saad Amer (around 39:00:00).

We need “a smooth transition between administrations” to ensure “steady, uninterrupted leadership” at the scientific agencies like the U.S. Food and Drug Administration (FDA), which is responsible for approving these technologies, and the Centers for Disease Control and Prevention (CDC), which is mapping distribution of them, she continued.

It’s also essential that “the public trusts the science agencies to fulfill their missions, which have been authorized and funded and have oversight from Congress,” said Dr. France Córdova, past director of the National Science Foundation. “The future of science in America depends on scientific integrity and relies on the trust of its citizens.” 

“The COVID vaccines have been through more scrutiny and more examination than almost any vaccine in history,” said Dr. Michelle. “There are so many eyes on this process that when we get vaccines out to patients, they’re going to be some of the most trusted vaccines ever developed.”

 
Dr. Michelle speaks during the Aspen Institute's Future of Science in America Summit
 

In the meantime, “we’ll have to find a way to keep hitting home the importance of mask wearing, social distancing, limiting social gatherings, and not traveling if it’s not absolutely necessary—because we still are not out of the woods even though we see some promising breakthroughs,” she concluded. 

Other conversations touched on environmental justice, advancing scientific literacy, and engaging scientists in the policymaking process—watch the whole thing.

 

More Health Care News: 

BioCentury: FDA to post data on COVID-19 therapeutic, vaccine EUAs
“Responding to public criticism of some of its COVID-19 emergency use authorization decisions, as well as a recommendation from a government watchdog agency, FDA announced Tuesday that it will publicly post reviews of the scientific data and information supporting regulatory decisions about EUAs of COVID-19 therapeutics and biologics, including vaccines.” 

Bloomberg (Opinion) : Why Moderna’s vaccine win is a giant leap against pandemics
“Both leading vaccines use the same promising messenger RNA technology, and their combined excellent early results suggest the world has a crucial new tool to respond quickly to diseases.” 

Reuters: Congo declares end of Ebola outbreak, sees lessons for COVID fight
“‘The technology used to keep the Ebola vaccine at super-cold temperatures will be helpful when bringing a COVID-19 vaccine to Africa,’ said WHO’s Africa director, Matshidiso Moeti.”

 
Twitter
 
LinkedIn
 
Facebook
 
 
California Life Sciences Association Annual Event - Register for FREE with Code GDB2020
 
 

On December 3, the California Life Sciences Association will host their event, Pantheon 2020: Recognizing Progress in an Unprecedented Year. This interactive 90-minute virtual event will feature video reels highlighting outstanding life sciences progress in 2020, engaging panel discussions with leading members of the life sciences sector, and virtual networking with fellow attendees and companies. 

Don’t miss BIO’s mainstage panel discussion moderated by BIO President and CEO Dr. Michelle McMurry-Heath with Dr. George Scangos, Dr. Sue Desmond-Hellmann, and Alan Mendelson exploring the challenges of 2020 and looking ahead to 2021. 

We have a special registration deal exclusively for Good Day BIO readers! The first 50 people to register will receive complimentary registration—enter code GDB2020 at checkout!

Tickets are $49 and 100% of proceeds will support three California non-profits: Alameda Health System FoundationCancer Support Community SF, and NexGeneGirls.

Register for Pantheon 2020!

 

 
 
 
Twitter
 
LinkedIn
 
Facebook
 
 
BIO Beltway Report
BIO Beltway Report
 
Paragraph (sm) - Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Quis ipsum suspendisse ultrices gravida. Risus commodo viverra maecenas accumsan lacus vel facilisis sample link.
 

President Trump’s Thursday: No public events scheduled.

President-Elect Biden’s Thursday: POLITICO profiles Yale researcher Dr. Marcella Nunez-Smith, the “Biden adviser focused on the pandemic’s stark racial disparities.” 

What’s Happening on Capitol Hill:House Democrats reelected Nancy Pelosi as Speaker for the next Congress.

 
 
Paragraph (normal) - Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Quis ipsum suspendisse ultrices gravida. Risus commodo viverra maecenas accumsan lacus sample link.
 
Twitter
 
LinkedIn
 
Facebook